Literature DB >> 21559742

Pathophysiological investigation of the gastric surface mucous gel layer of patients with Helicobacter pylori infection by using immunoassays for trefoil factor family 2 and gastric gland mucous cell-type mucin in gastric juice.

Seiko Kubota1, Kazuyoshi Yamauchi, Mitsutoshi Sugano, Kenji Kawasaki, Atsushi Sugiyama, Kenji Matsuzawa, Taiji Akamatsu, Yasukazu Ohmoto, Hiroyoshi Ota.   

Abstract

BACKGROUND: The trefoil factor family (TFF) 2 protein is produced by gastric gland mucous cells (GMCs), and the secreted TFF2 shares a mucosal barrier function with GMC-type mucin. Recently, we presented an enzyme-linked immunosorbent assay (ELISA) method for measurement of GMC-type mucin in the gastric juice. AIMS: We aimed to develop an ELISA for TFF2 and to assess pathophysiological changes in the gastric surface mucous gel layer (SMGL) of patients with Helicobacter pylori infection.
METHODS: The distribution of TFF2 and GMC-type mucin in the SMGL was immunohistochemically determined. The ELISA for TFF2 was based on a polyclonal goat antibody. Recombinant TFF2 was employed to prepare the calibrators. TFF2 and GMC-type mucin in the gastric juice in healthy individuals (n = 33) and patients with gastritis (n = 37), gastric ulcer (n = 16), and duodenal ulcer (n = 10) were assayed using ELISA.
RESULTS: TFF2 and GMC-type mucin were immunohistochemically co-localized in the gastric SMGL and GMCs. The TFF2 levels in the patients were significantly higher than those in the healthy individuals. Further, the TFF2 levels in the H. pylori-positive patients were significantly higher than those in the H. pylori-negative patients, and decreased after the eradication of the infection. GMC-type mucin levels showed a tendency similar to that of TFF2 levels.
CONCLUSIONS: The upregulation of TFF2 and GMC-type mucin secretion may reflect the response of the gastric mucosa to H. pylori-induced injuries. TFF2 and GMC-type mucin secreted into the SMGL may protect the gastric mucosa against H. pylori.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21559742     DOI: 10.1007/s10620-011-1724-9

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  36 in total

Review 1.  Trefoil peptides.

Authors:  W M Wong; R Poulsom; N A Wright
Journal:  Gut       Date:  1999-06       Impact factor: 23.059

2.  Human spasmolytic polypeptide decreases proton permeation through gastric mucus in vivo and in vitro.

Authors:  S Tanaka; D K Podolsky; E Engel; P H Guth; J D Kaunitz
Journal:  Am J Physiol       Date:  1997-06

3.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

4.  Helicobacter pylori cagA gene and expression of cytokine messenger RNA in gastric mucosa.

Authors:  Y Yamaoka; M Kita; T Kodama; N Sawai; J Imanishi
Journal:  Gastroenterology       Date:  1996-06       Impact factor: 22.682

5.  Trefoil factor 2 in gland mucous cell mucin in the mucous gel covering normal or damaged gastric mucosa using the Mongolian gerbil model.

Authors:  Kazufumi Suzuki; Masayoshi Hayama; Michitaka Nakamura; Kazuyoshi Yamauchi; Fukuto Maruta; Shinichi Miyagawa; Hiroyoshi Ota
Journal:  Scand J Gastroenterol       Date:  2006-12       Impact factor: 2.423

6.  Helicobacter pylori and the surface mucous gel layer of the human stomach.

Authors:  T Shimizu; T Akamatsu; A Sugiyama; H Ota; T Katsuyama
Journal:  Helicobacter       Date:  1996-12       Impact factor: 5.753

7.  Mechanism of hypoxia-inducible factor 1 alpha-mediated Mcl1 regulation in Helicobacter pylori-infected human gastric epithelium.

Authors:  Asima Bhattacharyya; Ranajoy Chattopadhyay; Emily H Hall; Semret T Mebrahtu; Peter B Ernst; Sheila E Crowe
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2010-09-09       Impact factor: 4.052

8.  Effects of a novel histamine H2-receptor antagonist, lafutidine, on the mucus barrier of human gastric mucosa.

Authors:  Takafumi Ichikawa; Hiroyoshi Ota; Atsushi Sugiyama; Fukuto Maruta; Tomoaki Ikezawa; Kyoko Hotta; Kazuhiko Ishihara
Journal:  J Gastroenterol Hepatol       Date:  2007-11       Impact factor: 4.029

9.  The trefoil protein TFF1 is bound to MUC5AC in human gastric mucosa.

Authors:  M-H Ruchaud-Sparagano; B R Westley; F E B May
Journal:  Cell Mol Life Sci       Date:  2004-08       Impact factor: 9.261

10.  Oral trefoil peptides protect against ethanol- and indomethacin-induced gastric injury in rats.

Authors:  M W Babyatsky; M deBeaumont; L Thim; D K Podolsky
Journal:  Gastroenterology       Date:  1996-02       Impact factor: 22.682

View more
  5 in total

Review 1.  Structure, Function, and Therapeutic Potential of the Trefoil Factor Family in the Gastrointestinal Tract.

Authors:  Nayara Braga Emidio; Stuart M Brierley; Christina I Schroeder; Markus Muttenthaler
Journal:  ACS Pharmacol Transl Sci       Date:  2020-06-09

2.  Different Forms of TFF2, A Lectin of the Human Gastric Mucus Barrier: In Vitro Binding Studies.

Authors:  Franziska Heuer; René Stürmer; Jörn Heuer; Thomas Kalinski; Antje Lemke; Frank Meyer; Werner Hoffmann
Journal:  Int J Mol Sci       Date:  2019-11-22       Impact factor: 5.923

3.  Helicobacter pylori Infection and the Patterns of Gastric Mucin Expression in Children.

Authors:  Ana-Maria Teodora Domșa; Raluca Lupușoru; Dan Gheban; Alexandra Buruiană-Simic; Bogdan Alexandru Gheban; Camelia Lazăr; Cristina Maria Borzan
Journal:  J Clin Med       Date:  2020-12-13       Impact factor: 4.241

4.  Trefoil factor-2, an early predictor for acute gastrointestinal injury in patients with acute pancreatitis.

Authors:  Rong-Li Xie; Wei-Wei Chen; Meng-Zhi Qi; Dan Tan; Bing Zhao; Jie Huang; Lei Li; Jin-Long Wang; Ming Zhong; Jianmin Yuan; Jian Fei; Ying Chen; En-Qiang Mao; Erzhen Chen
Journal:  Medicine (Baltimore)       Date:  2021-07-16       Impact factor: 1.817

5.  Helicobacter pylori infection progresses proximally associated with pyloric metaplasia in age-dependent tendency: a cross-sectional study.

Authors:  Huiying Shi; Hanhua Xiong; Wei Qian; Rong Lin
Journal:  BMC Gastroenterol       Date:  2018-10-29       Impact factor: 3.067

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.